INIS · XBRL financial data

Radnostix financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (INIS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	9,365	9,662	11,182	12,267	13,900	13,070
Cost of goods and services sold	3,905	3,924	4,892	4,888	5,251	5,368
Gross profit	5,460	5,738	6,290	7,379	8,649	7,703
Research and development	219	272	534	577	611	436
General and administrative	2,828	3,459	3,569	3,546	4,009	3,733
Total operating expenses	5,876	6,419	7,493	8,155	8,642	8,659
Operating income (loss)	(416)	(681)	(1,203)	(776)	7	(956)
Interest income	3	0	10	79	122	77
Interest expense	782	792	614	332	329	339
Other income (expense)	3,637	683	2,111	160	208	311
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	2,203	(902)	303	(869)	9	(908)
Earnings per share, basic USD per share	0.01	0.00	0.00	0.00	0.00	0.00
Earnings per share, diluted USD per share	0.01	0.00	0.00	0.00	0.00	0.00
Weighted average shares, basic thousands of shares	423,091	477,724	510,794	517,778	522,289	526,795
Weighted average shares, diluted thousands of shares	431,209	477,724	510,794	517,778	522,289	526,795

Fiscal years (INIS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,113	475	2,376	2,688	1,946	1,695
Accounts receivable	796	854	1,597	1,469	1,521	1,418
Inventory	838	925	745	927	821	875
Prepaid and other current assets	—	—	1,023	673	698	636
Total current assets	3,994	3,258	5,741	5,757	4,986	4,625
Property and equipment, net	4,490	4,300	2,024	2,465	3,298	3,690
Right-of-use asset	2,540	2,430	2,311	2,184	2,048	2,846
Goodwill	1,384	1,384	1,384	1,384	1,384	1,384
Total assets	17,097	16,327	16,245	16,905	17,161	17,837
Accounts payable	2,115	1,424	382	560	862	1,531
Accrued liabilities	1,205	1,189	1,473	1,482	1,495	1,704
Current portion of long-term debt	481	290	23	—	308	163
Total current liabilities	5,662	4,935	3,515	3,274	3,329	3,974
Lease liability, non-current	2,484	2,364	2,232	2,092	1,941	2,720
Total liabilities	14,209	13,596	11,902	12,868	12,814	14,144
Accumulated deficit	(125,862)	(126,764)	(126,461)	(127,330)	(127,321)	(128,229)
Total stockholders' equity	574	2,731	4,343	4,037	4,347	3,693
Total liabilities and equity	17,097	16,327	16,245	16,905	17,161	17,837
Common shares outstanding (cover page) thousands of shares	460,387	503,167	514,993	520,081	523,706	528,210

Fiscal years (INIS's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	2,203	(902)	303	(869)	9	(908)
Stock-based compensation	88	85	352	464	199	118
Depreciation and amortization	300	581	374	350	401	402
Net cash from operating activities	1,150	(162)	(1,498)	583	639	620
Purchases of property and equipment	8	205	120	149	721	534
Net cash from investing activities	28	(205)	3,880	(149)	(685)	(534)
Proceeds from issuing common stock	—	—	77	8	12	—
Net cash from financing activities	(637)	(79)	(472)	(81)	(145)	(276)
Net change in cash	541	(446)	1,910	353	(192)	(190)

SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Radnostix	1,196	2,672	(614)*	529.2M	2.0 quarters	Q2 FY26 10-QJun 30, 2026
Electro Sensors	10,756	not reported	68	3.5M	—	Q1 FY26 10-QMar 31, 2026
ASTROTECH	8,387	not reported	(2,288)*	2.0M	5.0 quarters	Q4 FY26 10-KJun 30, 2026
Syntec Optics Holdings	14,047	8,274	(299)*	40.3M	47.0 quarters	Q2 FY26 10-QJun 30, 2026
Scientific Industries	617	1,470	(904)*	11.9M	5.0 quarters	Q2 FY26 10-QJun 30, 2026
Bionano Genomics	3,730	8,171	(4,670)*	11.8M	2.1 quarters	Q2 FY26 10-QJun 30, 2026
Bioforce Nanosciences Holdings	0.3	not reported	(27)*	33.5M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Focus Universal	1,600	675	(741)*	702,745	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Precipio	3,075	7,021	660*	1.8M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.